 |
인쇄하기
취소
|
Adalat Oros differs from general products in pharmacokinetic profiles, BayerSchering HealthCare says
All once-daily nifedipine formulations are not pharmacokinetically the same, according to clinical data released by BayerSchering HealthCare on March 3.
Citing the theses published by British Journal of Clinical Pharmacology and Clinical Therapeutics, the company claims that when substituting a reference drug with an approved generic drug for cost reasons, regulatory authorities should ensur...
Citing the theses published by British Journal of Clinical Pharmacology and Clinical Therapeutics, the company claims that when substituting a reference drug with an approved generic drug for cost reasons, regulatory authorities should ensur...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.